http://www.cnr.it/ontology/cnr/individuo/prodotto/ID15243
Ceratamines, Structurally Simple Microtubule-Stabilizing Antimitotic Agents with Unusual Cellular Effects (Articolo in rivista)
- Type
- Label
- Ceratamines, Structurally Simple Microtubule-Stabilizing Antimitotic Agents with Unusual Cellular Effects (Articolo in rivista) (literal)
- Anno
- 2005-01-01T00:00:00+01:00 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
- 10.1158/0008-5472.CAN-04-4369 (literal)
- Alternative label
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Karjala G.; Chan Q.; Manzo E.; Andersen R.J.;Roberge M. (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
- http://cancerres.aacrjournals.org/content/65/8/3040.abstract (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
- Note
- ISI Web of Science (WOS) (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Departments of 1Biochemistry and Molecular Biology and 2Chemistry and Oceanography (EOS), University of British Columbia, Vancouver, British Columbia, Canada
Istituto di Chimica Biomolecolare, Consiglio
Nazionale delle Ricerche, Via Campi Flegrei 34, I 80078 Pozzuoli, Naples, Italy. (literal)
- Titolo
- Ceratamines, Structurally Simple Microtubule-Stabilizing Antimitotic Agents with Unusual Cellular Effects (literal)
- Abstract
- Ceratamine A and ceratamine B are heterocyclic alkaloids
recently identified in a screen for compounds that arrest cells
in mitosis. Treatment of breast carcinoma MCF-7 cells causes
a concentration-dependent block of cell cycle progression
exclusively at mitosis. In vitro studies with purified tubulin
indicate that the ceratamines directly stimulate microtubule
polymerization in the absence of microtubule-associated
proteins. Cells treated with ceratamines show a dense
perinuclear microtubule network in interphase and multiple
pillar-like tubulin structures in mitotic cells. The ceratamines
do not compete with paclitaxel for binding to microtubules
in vitro. Unlike other microtubule-stabilizing agents, the
ceratamines have simple structures with no chiral centers,
making them attractive drug leads. (Cancer Res 2005; 65(8):
3040-3) (literal)
- Prodotto di
- Autore CNR
Incoming links:
- Autore CNR di
- Prodotto
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi